All About Hepatitis
What is hepatitis?
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D
Hepatitis E
Living with Hepatitis
Entry 112219
Testing and treatment
Testing
Treatment Options
Broschüre Hepatitis C
Projects and campaigns
The Swiss Hepatitis Strategy
Projects
Symposiums
News
News
Press
Specialists
Chronic hepatitis
Hepatitis B
Hepatitis C
Publications and links
Recommendations
About us
Who we are
Core tasks and goals
The network
Members
Sponsors and partners
Annual Report
Jobs
Publications and links
Information material
Hepatitis A
Hepatitis A in der Schweiz. Bulletin des BAG vom 04.06.2018
(PDF)
Hepatitis B
Flyer "What is hepatitis B?"
(PDF)
Hepatitis C
Hepatitis C – the most important questions and answers (in German, also available in French and Italian)
(PDF)
Leaflet "What is hepatitis C?"
(PDF)
Links
Switzerland
Arud Center for Addiction Medicine
Federal Office for Public Health
Swiss Hepatitis C Association
Infodrog
Lovelife - Campaign for the prevention of HIV and sexually transmitted infections
Positive Council Switzerland
Swiss Society for Gastroenterology
Swiss Society for Infectious Diseases
Swiss Association for the Study of the Liver
SwissHePa
Swiss Association for Public Health
International
World Health Organization WHO
World Hepatitis Alliance
International World Hepatitis Day
FixHepC Buyers Club
Liver Patients International
NoHep - the global movement to eliminate viral hepatitis by 2030
Projects websites Swiss Hepatitis
HepCare - Hepatitis C therapy at the GP
HepCheck - Check risks and find testing sites
SHiPP Swiss Hepfree in Prisons Programme
Studies and articles
2024
HEV ORF2 protein-antibody complex deposits are associated with glomerulonephritis in hepatitis E with reduced immune status. Nature Communications
Leblond A-L, Helmchen B, Ankavay, M et al.
Nature Communications, 8849 (2024) — 14.10.2024
Hepatitis C prevalence and cascade of care among patients in the decentralised opioid agonist therapy programme of the canton of St Gallen, Switzerland: a cross-sectional study
Wissel K, Vernazza P, Kuster S, Hensel-Koch K, Bregenzer A
Swiss Medical Weekly 2024;154:3352 — 29.02.2024
Late presentation for hepatitis C treatment: prevalence and risk factors in the Swiss Hepatitis C Cohort
Brunner N, Grischott T, Bruggmann P, and the Swiss Hepatitis C Cohort Study Group
European Journal of Gastroenterology & Hepatology — 23.01.2024
2023
Letter to the Editor, Dec. 23: Assessing the hepatitis C epidemiology in Switzerland: It is not that trivial
Razavi H, Blach S, Bregenzer A, Bruggmann P, Cerny A, Maeschli B, et al.
Journal of Viral Hepatitis
Elimination von Hepatitis C: Das Potenzial der Apotheken
Maeschli B, Messerli M
pharmaJournal, 8, 2023
Elimination de l'hépatite C: Le potentiel des pharmacies
Maeschli B, Messerli M
pharmaJournal, 8, 2023
Assessing the hepatitis C epidemiology in Switzerland: it’s not that trivial
Blach S, Bregenzer A, Bruggmann P, Cerny A, Maeschli B, Müllhaupt B, et al.
J Viral Hepat. 2023;00:1-2.
Mortality and morbidity related to hepatitis C virus infection in hospitalized adults—A propensity score matched analysis
Hovaguimian F, Beeler PE, Müllhaupt B, Günthard HF, Maeschli B, Bruggmann P, Fehr JS, Kouyos RS
Journal of Viral Hepatitis
Hepatitis C virus screening in community pharmacies: results on feasibility from a Swiss pilot. BMC Infect Dis 23, 384 (2023).
Stämpfli D, Imfeld-Isenegger T.L., Hersberger K.E. et al.
BMC Infectious Disease
The current and future burden of hepatitis B in Switzerland: a modelling study
Negro F, Müllhaupt B, Semela D, Blach S et al.
Swiss Medical Weekly
Hepatitis C antibody test frequencies and positive rates in Switzerland from 2007 to 2017: a retrospective longitudinal study
Agosti-Gonzaleza R, Falcato L, Grischott T, Senn O, Bruggmann P
Swiss Medical Weekly
Hepatitis C lässt sich in der stationären Psychiatrie einfach behandeln
Maeschli B, Bruggmann P
Schweizer Zeitschrift für Psychiatrie und Neurologie
Eliminating viral hepatitis B and C in times of war and increasing global refugee crisis
Bruggmann P
Swiss Medical Weekly, Vol. 153 No. 4 (2023)
2022
HCV elimination in a Swiss opioid agonist therapy programme – a cohort study
Bregenzer A, Krismer C, Wendel S, Roser P, Fux C
Swiss Medical Weekly
Hausärztinnen und Hausärzte dürfen neu Hepatitis-C-Behandlungen selbst verschreiben
Maeschli B, Bruggmann P
Primary and Hospital Care
Les médecins de famille peuvent désormais prescrire des traitements contre l’hépatite C
Maeschli B, Bruggmann P
Primary and Hospital Care
Screening auf Hepatitis B und C sowie HIV bei Erwachsenen aus der Ukraine
Bruggmann P, Scheidegger C, Semela D
Swiss Med Forum. 2022;22(37):610-611
Recommandations de la SSI, de la SASL et d’Hépatite Suisse: Dépistage de l'hépatite B et C et du VIH chez les adultes originaires d'Ukraine
Bruggmann P, Scheidegger C, Semela D
Forum Med Suisse. 2022;22(37):610-611
“Shaping the new freedom”: A reflexive thematic analysis on patients’ post cure needs after years of living with hepatitis C
Guggisberg H, Nicca D, Kohler A, Bruggmann P, Künzler-Heule P
Swiss Medical Weekly, 2022;152:w30177
The hepatitis C cascade of care in HIV/hepatitis C virus coinfected individuals in Europe: regional and intra-regional differences
Fursa O, Mocroft A, Lazarus JV, Amele S, Lundgren J, Matulionyte R, Rasmussen LD, Rockstroh JK, et al.
AIDS. 2022 Mar 1;36(3):423-435
How to set the agenda for hepatitis C: A theory driven analysis
Kind J, Maeschli B, Bruggmann P
Health Research Policy and Systems
2021
HCV disease burden and population segments in Switzerland
Bihl F, Bruggmann P, Castro Batanjër E, et al.
Liver International
Warum wir an die Italiener denken sollten
Maeschli B, Gagliotta E, Bruggmann P
Schweizerische Ärztezeitung
Pourquoi nous devrions penser aux Italiens
Maeschli B, Gagliotta E, Bruggmann P
Bulletin des médecins suisses
Response to a sexual risk reduction intervention provided in combination with hepatitis C treatment by HIV/HCV co-infected men who have sex with men: a reflexive thematic analysis
Künzler-Heule P, Fierz K, Schmidt A-J, Rasi M et al.
BMC Infect Dis 21, 319 (2021)
Nachsorge nach erfolgreicher Hepatitis-C-Therapie: Eine geteilte Verantwortung
Schmid P
Swiss Med Forum. 2021;21(1112):177-178
Empfehlungen für die Nachsorge von Patientinnen/Patienten mit ausgeheilter Hepatitis C
Bobzin C, Bösiger Ch, Bruggmann P et al.
Swiss Med Forum. 2021;21(1112):184-186
Recommandations pour le suivi des patients atteints d’hépatite C guérie
Bobzin C, Bösiger Ch, Bruggmann P et al.
Recommandations pour le suivi des patients atteints d’hépatite C guérie
Suivi après un traitement réussi de l’hépatite C: Une responsabilité partagée
Schmid P
Forum Med Suisse. 2021;21(1112):177-178
Hepatitis C virus elimination in Swiss opioid agonist therapy programmes – the SAMMSU cohort
Bregenzer A, Bruggmann P, Castro E, Moriggia A, Rothen M, Thurnheer M C, Vernazza P, Scheidegger C
Swiss Medical Weekly
Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection
Page K, Melia M, Veenhuis R
N Engl J Med 2021; 384:541-549
2020
The Swiss STAR trial – an evaluation of target groups for sexually transmitted infection screening in the sub-sample of men
Schmidt A, Rasi M, Esson C et al.
Swiss Med Wkly. 2020;150:w20392
The Swiss STAR trial – an evaluation of target groups for sexually transmitted infection screening in the sub-sample of women
Vernazza P, Rasi M, Ritzler M et al.
Swiss Med Wkly. 2020;150:w20393
Update Virushepatitis B und C: Der Beitrag der Schweiz zur weltweiten Krankheitselimination - Teil 2: Hepatitis B im Fokus
Bechlera A, Schmassmann A
Swiss Medical Forum. 2020;20(4546):642-646
Update Virushepatitis B und C: Der Beitrag der Schweiz zur weltweiten Krankheitselimination - Teil 1: Übersicht Hepatitis B und C sowie Hepatitis C im Fokus
Bechlera A, Schmassmann A
Swiss Med Forum. 2020;20(4344):597-601
Hepatitis C micro-elimination among people on opioid agonist therapy is a low-hanging fruit
Bruggmann P, Maeschli B
Swiss Med Wkly. 2020;150:w20348
Management of hepatitis C in opioid agonist therapy patients of the Swiss canton Aargau within and outside the cohort study
Schürch S, Fux C, Dehler S, Conen A, Knuchel J, Friedl A, et al.
Swiss Med Wkly. 2020.;150:w20317
Chronic hepatitis D and hepatocellular carcinoma: A systematic review and meta-analysis of observational studies
Alfaiate D, Clément S, Gomes D et al.
Journal of Hepatology, Volume 73, ISSUE 3, P533-539
Das HepCare-Projekt macht’s möglich: Hepatitis-C-Behandlungen in der hausärztlichen Praxis
Bruggmann P, Maeschli B, Scheidegger C
Primary and Hospital Care
Avec le projet HepCare, c’est possible: Traitements de l’hépatite C au cabinet du médecin de famille
Bruggmann P, Maeschli B, Scheidegger C
Prim Hosp Care Med Int Gen. 2020;20(02):67-69
Die Elimination von viraler Hepatitis: ein grosser Beitrag an die Krebsprävention
Bruggmann P, Maeschli B, Mertens J, Müllhaupt B
Schweizer Krebsbulletin 1/2020
2019
Hepatitis C in der Schweiz, epidemiologische Situation 2015–2018
Bundesamt für Gesundheit BAG
BAG-Bulletin 45/2019
Hépatites C en Suisse, situation épidémiologique en 2015–2018
Office fédéral de la santé publique
OFSP-Bulletin 45/2019
Une mission gratifiante pour le médecin de famille: Hépatite C – histoire d’un succès
Bruggmann P
Prim Hosp Care Med Int Gen. 2018;18(16)
Eine dankbare Aufgabe für die Hausärztin: Hepatitis C – Eine Erfolgsgeschichte
Bruggmann P
Prim Hosp Care Allg Inn Med. 2018;18(16)
The Swiss Hepatitis Strategy as a model for facing future health policy challenges
Blindenbacher R, Maeschli B, Bruggmann P
Health Policy, Volume 123, Issue 7, July 2019, Pages 681-687
Impact of geographic origin on access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study
Terziroli Beretta-Piccoli B, Semmo N, Müllhaupt B, Semela D, Negro F, Keiser O, for the Swiss Hepatitis C Cohort Study
PLOS ONE
Very Low Hepatitis C Viral Loads in Treatment-naive Persons: Do They Compromise Hepatitis C Virus Antigen Testing?
Bertisch B, Brezzi M, Negro F, Müllhaupt B, Ottiger C, Künzler-Heule P, Schmid P, Giudici F, Clerc O, Moriggia A, Roelens M, Marinucci F, Zehnder C, Moradpour D, Keiser O, Swiss Hepatitis C Cohort Study
Clinical Infectious Diseases, ciz270,
Cost-effectiveness analysis of strategies to manage the disease burden of hepatitis C virus in Switzerland
Blach S, Schaetti C, Bruggmann P, Negro F, Razavi H
Swiss Med Wkly. 2019;149:w20026
Controlling HCV in Switzerland: running against the clock
Cerny A, Blindenbacher R, Moriggia A
Swiss Med Wkly. 2019;149:w20005
Schweizer OAT-Programme auf ihrem Weg zur HCV-Elimination - Die SAMMSU-Kohorte
Bregenzer A, Bruggmann P, Castro E, Moriggia A, Rothen M, Thurnheer M, Vernazza P, Scheidegger C
Suchtmedizin Nr. 21, 2/2019, pp. 75-90
Chronische virale Hepatitiden
Gruber M, De Gottardi A
Prim Hosp Care Allg Inn Med. 2019;19(03):77-81
Im Schatten von HIV: Das „Aschenbrödel“ Hepatitis C
Kind J, Maeschli B, Bruggmann P
Suchtmedizin 2/2019
Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regions
Rusch U, Robbins S, Razavi H, Vernazza P, Blach S, Bruggmann P, et al.
Swiss Med Wkly. 2019;149:w14694
Hepatitis A in Switzerland: An analysis of 29 years of surveillance data and contemporary challenges
Schmutz C, Mäusezahl D, Jost M
Travel Medicine and Infectious Disease, Volume 27, Jan-Feb 2019, pp 53-63
2018
Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030?
Müllhaupt B, Bruggmann P, Bihl F, Blach S, Lavanchy D, Razavi H, et al.
PLoS ONE 13(12): e0209374
Blood-borne and sexually transmitted infections: a cross-sectional study in a Swiss prison
Chacowry Pala K, Baggio S, Toan Tran N, Girardin F, Wolff H, Gétaz L
BMC Infectious Diseases volume 18, Article number: 539
Impact of Screening and Treatment for Hepatitis C Virus (HCV) Infection in Switzerland A Comprehensive Mathematical Model of the Swiss HCV Epidemic Summary
Estill J, Sadeghimer M, Keiser O, Bertisch B
Institute of Global Health, University of Geneva
Hepatitis B in der Schweiz, epidemiologische Situation 2014–2017
Bundesamt für Gesundheit BAG
BAG-Bulletin 35/18, S. 7ff.
Hépatites B en Suisse, situation épidémiologique en 2014–2017
Office fédéral pour la santé publique OFSP
Bulletin de l’OFSP 35/18, p. 7 ss
A buyers’ club to improve access to hepatitis C treatment for vulnerable populations
Vernaz N, Calmy A, Hurst S, Jackson Y, Negro F, Perrier A, Wolff H
Swiss Med Wkly. 2018;148:w14649
Hepatitis B prevalence, risk factors, infection awareness and disease knowledge among inmates: a cross-sectional study in Switzerland’s largest pre-trial prison
Gétaz L, Casillas A, Siegrist C-A, Chappuis F, Togni G, Tran N-T, Baggio S, Negro F, Gaspoz J-M, Wolff H
Journal of Global Health, Vol. 8 No. 2
The epidemiology of hepatitis C in Switzerland: trends in notifications, 1988–2015
Richard J-L, Schaetti C, Basler S, Mäusezahl M
Swiss Med Wkly. 2018;148:w14619
Die Hepatitis-C-Epidemiologie in der Schweiz und die Rolle der Grundversorgung
Bruggmann P
Praxis (2016), 105, pp. 885-889
Excellent outcome of direct antiviral treatment for chronic hepatitis C in Switzerland
Bachofner J at al.
Swiss Med Wkly. 2018;148:w14560
Hepatitis-C-Prävention: Vorsicht, Viren auf der Klinge!
Journal Coiffeur Suisse
Hépatite C – Prévention: Prudence, des virus sur la lame!
Journal Coiffeur Suisse
Prevenzione contro l’epatite C: Attenzione, virus sulle lame!
Journal Coiffeur Suisse
2017
Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade
Bregenzer A, Conen A, Knuchel J, Friedl A, Eigenmann F, Näf M, Ackle P, Roth M, Fux C
Swiss Med Wkly. 2017;147:w14544
Trends in hepatitis C- related mortality in Switzerland.
Keiser O, Giudici F, Mullhaupt B, Junker C, Dufour JF, Moradpour D, et al.
J Viral Hepat. 2018;25(2):152-60.
Situationsanalyse Hepatitis B und C in der Schweiz
Keiser O, Bertisch B, Zahnd C, et al.
Institut für Sozial und Präventivmedizin der Universität Bern
Reduction of acute hepatitis B through vaccination of adolescents with no decrease in chronic hepatitis B due to immigration in a low endemicity country
Richard J-L, Schaetti Ch, Basler S, Masserey Spicher V
Swiss Med Wkly. 2017/07-08
2016
Characteristics of Foreign-Born Persons in the Swiss Hepatitis C Cohort Study: Implications for Screening Recommendations
Bertisch B, Giudici F, Negro F, Moradpour D, Müllhaupt B, Moriggia A, et al.
PLOS ONE, 11(5)
Hepatitis-C-Elimination in der Schweiz: Was kann der Hausarzt dazu beitragen?
Bruggmann P
Der informierte Arzt
2015
Birth year distribution in reported hepatitis C cases in Switzerland
Bruggmann P, Richard J-R, on behalf of the Swiss Hepatitis C Cohort Study Group
European Journal of Public Health, Volume 25, Issue 1, February 2015,
Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland
Müllhaupt B, Bruggmann P, Bihl F, Blach S, Lavanchy D, Razavi H, Semela D, Negro F
PLOS ONE, 10(6)
2014
Global epidemiology and genotype distribution of the hepatitisC virus infection
Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H
Journal of Hepatology2014vol. 61jS45–S57
2013
Hepatitis B and C in Switzerland – healthcare provider initiated testing for chronic hepatitis B and C infection
Fretz R, Negro F, Bruggmann P, Lavanchy D, De Gottardi A, Pache I, Masserey Spicher V, A Cerny
Swiss Med Wkly. 2013;143:w13793
Prävention blutübertragbarer Krankheiten auf Patienten: Empfehlungen für Personal im Gesundheitswesen mit Hepatitis B-, Hepatitis C- oder HIV-Infektion
Bundesamt für Gesundheit BAG, Referenzzentren für blutübertragbare Infektionen im Gesundheitsbereich
Recommandations pour le personnel de santé infecté par les virus de l’hépatite B, de l’hépatite C ou de l’immunodéficience humaine : prévention du risque de transmission aux patients
Office fédéral de la santé publique OFSP, Centres de référence pour les infections transmissibles par le sang dans le secteur sanitaire
2012
Hepatitis C Virus Infections in the Swiss HIVCohort Study: A Rapidly Evolving Epidemic
Wandeler G et al.
Clinical Infectious Disease 2012:55
All About Hepatitis
What is hepatitis?
Hepatitis A
Hepatitis B
Hepatitis C
Hepatitis D
Hepatitis E
Living with Hepatitis
Entry 112219
Testing and treatment
Testing
Treatment Options
Broschüre Hepatitis C
Projects and campaigns
The Swiss Hepatitis Strategy
Projects
Symposiums
News
News
Press
Specialists
Chronic hepatitis
Hepatitis B
Hepatitis C
Publications and links
Recommendations
About us
Who we are
Core tasks and goals
The network
Members
Sponsors and partners
Annual Report
Jobs